UNVERIFIEDSingle SourceAnother weight-loss pill in the works, as Ozempic-maker Novo Nordisk strikes deal with Boston startupThe Boston Globe|2/25/2026
UNVERIFIEDSingle SourceStocks making the biggest moves midday: IBM, AMD, Dillard's, Novo Nordisk, Keysight Technologies & moreCNBC|2/24/2026
UNVERIFIEDSingle SourceStocks making the biggest moves premarket: Arcellx, Novo Nordisk, Domino's Pizza and more CNBC|2/23/2026
UNVERIFIEDSingle SourceNovo Nordisk slump wipes out last Wegovy-era gains after trial setbackReuters|2/23/2026
UNVERIFIEDSingle SourceNovo Nordisk shares drop after poor trial results for new obesity drugFinancial Times|2/23/2026
UNVERIFIEDSingle SourceNovo Nordisk's obesity drug CagriSema falls short against Eli Lilly's in trialReuters|2/23/2026
UNVERIFIEDSingle SourceStocks making the biggest moves premarket: Oracle, Novo Nordisk, Hims & Hers Health, Kroger and moreCNBC|2/9/2026
UNVERIFIEDSingle SourceUS health company launches weight-loss pill that Novo Nordisk calls an 'untested knockoff'Euronews|2/6/2026
UNVERIFIEDSingle SourceWegovy-maker Novo Nordisk warns of 'unprecedented' price pressure as shares tumbleReuters|2/4/2026
UNVERIFIEDSingle SourceNovo Nordisk sees lower sales, profits as Wegovy faces growing competition - statnews.comStat News|2/3/2026
UNVERIFIEDSingle SourceStocks making the biggest moves midday: Novo Nordisk, Palantir, AES, Rocket and moreCNBC|2/3/2026
UNVERIFIEDSingle SourceBMO Raises Novo Nordisk A/S (NVO) Price Target but Flags Prescription PressuresInsider Monkey|1/31/2026
UNVERIFIEDSingle SourceNovo Nordisk wins 3,071 prescriptions for Wegovy pill (NVO:NYSE) - Seeking AlphaGoogle News|1/16/2026
UNVERIFIEDSingle SourceHealthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference - CNBCGoogle News|1/14/2026